Indegene Q3: Revenue Jumps 31% to ₹942 Cr, But Profit and Margins Dip
Earnings
C
CNBC TV18•29-01-2026, 19:52
Indegene Q3: Revenue Jumps 31% to ₹942 Cr, But Profit and Margins Dip
- •Indegene reported a 30.8% surge in Q3 revenue to ₹942 crore, achieving its first $100 million-plus revenue quarter.
- •Net profit for the quarter declined by 6.2% year-on-year to ₹102.9 crore.
- •EBITDA increased by 21.9% to ₹159.9 crore, but the operating margin narrowed to 17% from 18.2%.
- •The company attributed revenue growth to client momentum and AI-led productivity gains, with revenue per employee crossing $70,000 annually.
- •Indegene completed acquisitions of BioPharm and Warn & Co, strengthening domain expertise and high-value capabilities.
Why It Matters: Indegene's Q3 saw strong revenue growth driven by client momentum and acquisitions, despite a dip in profit and margins.
✦
More like this
Loading more articles...
